Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.23.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2023
Dec. 31, 2022
Current assets    
Cash and cash equivalents $ 6,715 $ 36,589
Restricted cash, current 3,725 3,426
Inventory 5,105 2,954
Prepaids and other current assets 11,452 9,350
Total current assets 26,997 52,319
Property and equipment, net 328,907 311,400
Restricted cash, non-current 10,600 10,600
Operating lease right-of-use assets 38,782 39,331
Deferred warrant asset 50,175 50,175
Deferred battery supplier cost 30,000 30,000
Other non-current assets 2,655 2,647
Total assets 488,116 496,472
Current liabilities    
Accounts payable 88,835 103,187
Accrued expenses and other current liabilities 85,945 63,091
Convertible debt, current 0 34,829
Warrant liability, current 0 17,171
Total current liabilities 174,780 218,278
Contingent earnout shares liability 508 3,013
Operating lease liabilities 38,076 38,608
Warrant liability, non-current 23,000 0
Total liabilities 236,364 259,899
Commitments and contingencies (Note 11)
Stockholders’ equity    
Preferred stock, $0.0001 par value; 10,000 authorized, no shares issued and outstanding at March 31, 2023 and December 31, 2022 0 0
Common stock, $0.0001 par value; 1,000,000 and 500,000 authorized as of March 31, 2023 and December 31, 2022, respectively; 475,598 and 355,388 issued and outstanding at March 31, 2023 and December 31, 2022, respectively 47 35
Additional paid-in capital 1,522,260 1,416,361
Accumulated deficit (1,270,555) (1,179,823)
Total stockholders’ equity 251,752 236,573
Total liabilities and stockholders’ equity $ 488,116 $ 496,472